BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30726574)

  • 1. Widespread microglial activation in multiple system atrophy.
    Kübler D; Wächter T; Cabanel N; Su Z; Turkheimer FE; Dodel R; Brooks DJ; Oertel WH; Gerhard A
    Mov Disord; 2019 Apr; 34(4):564-568. PubMed ID: 30726574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy.
    Gerhard A; Banati RB; Goerres GB; Cagnin A; Myers R; Gunn RN; Turkheimer F; Good CD; Mathias CJ; Quinn N; Schwarz J; Brooks DJ
    Neurology; 2003 Sep; 61(5):686-9. PubMed ID: 12963764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [
    Jucaite A; Cselényi Z; Kreisl WC; Rabiner EA; Varrone A; Carson RE; Rinne JO; Savage A; Schou M; Johnström P; Svenningsson P; Rascol O; Meissner WG; Barone P; Seppi K; Kaufmann H; Wenning GK; Poewe W; Farde L
    Mov Disord; 2022 Jan; 37(1):119-129. PubMed ID: 34609758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's Disease.
    Chou KL; Dayalu P; Koeppe RA; Gilman S; Spears CC; Albin RL; Kotagal V
    Mov Disord; 2022 Nov; 37(11):2301-2307. PubMed ID: 36102173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
    Stokholm MG; Iranzo A; Østergaard K; Serradell M; Otto M; Svendsen KB; Garrido A; Vilas D; Borghammer P; Santamaria J; Møller A; Gaig C; Brooks DJ; Tolosa E; Pavese N
    Lancet Neurol; 2017 Oct; 16(10):789-796. PubMed ID: 28684245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of dopamine transporter imaging in subtypes of multiple system atrophy.
    Bu LL; Liu FT; Jiang CF; Guo SS; Yu H; Zuo CT; Wu P; Wang J
    Acta Neurol Scand; 2018 Aug; 138(2):170-176. PubMed ID: 29573392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.
    Lyoo CH; Jeong Y; Ryu YH; Lee SY; Song TJ; Lee JH; Rinne JO; Lee MS
    Brain; 2008 Feb; 131(Pt 2):438-46. PubMed ID: 18178568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M; Kim JS; Kim JY; Shin KH; Park SH; Kim HO; Moon DH; Oh SJ; Chung SJ; Lee CS
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.
    Juh R; Kim J; Moon D; Choe B; Suh T
    Eur J Radiol; 2004 Sep; 51(3):223-33. PubMed ID: 15294329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial activation in young adults with autism spectrum disorder.
    Suzuki K; Sugihara G; Ouchi Y; Nakamura K; Futatsubashi M; Takebayashi K; Yoshihara Y; Omata K; Matsumoto K; Tsuchiya KJ; Iwata Y; Tsujii M; Sugiyama T; Mori N
    JAMA Psychiatry; 2013 Jan; 70(1):49-58. PubMed ID: 23404112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased striatal monoaminergic terminals in multiple system atrophy detected with positron emission tomography.
    Gilman S; Koeppe RA; Junck L; Little R; Kluin KJ; Heumann M; Martorello S; Johanns J
    Ann Neurol; 1999 Jun; 45(6):769-77. PubMed ID: 10360769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor activation in multiple system atrophy and Parkinson disease: a PET study.
    Payoux P; Brefel-Courbon C; Ory-Magne F; Regragui W; Thalamas C; Balduyck S; Durif F; Azulay JP; Tison F; Blin O; Esquerre JP; Rascol O
    Neurology; 2010 Sep; 75(13):1174-80. PubMed ID: 20876470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
    Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
    Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts.
    Ge J; Wu J; Peng S; Wu P; Wang J; Zhang H; Guan Y; Eidelberg D; Zuo C; Ma Y
    Hum Brain Mapp; 2018 Jul; 39(7):2842-2858. PubMed ID: 29536636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.
    Swanson RL; Newberg AB; Acton PD; Siderowf A; Wintering N; Alavi A; Mozley PD; Plossl K; Udeshi M; Hurtig H
    Eur J Nucl Med Mol Imaging; 2005 Mar; 32(3):302-7. PubMed ID: 15791439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglial activation parallels system degeneration in multiple system atrophy.
    Ishizawa K; Komori T; Sasaki S; Arai N; Mizutani T; Hirose T
    J Neuropathol Exp Neurol; 2004 Jan; 63(1):43-52. PubMed ID: 14748560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different loss of dopamine transporter according to subtype of multiple system atrophy.
    Kim HW; Kim JS; Oh M; Oh JS; Lee SJ; Oh SJ; Chung SJ; Lee CS
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):517-25. PubMed ID: 26384682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBB3 imaging in Parkinsonian disorders: Evidence for binding to tau and other proteins.
    Perez-Soriano A; Arena JE; Dinelle K; Miao Q; McKenzie J; Neilson N; Puschmann A; Schaffer P; Shinotoh H; Smith-Forrester J; Shahinfard E; Vafai N; Wile D; Wszolek Z; Higuchi M; Sossi V; Stoessl AJ
    Mov Disord; 2017 Jul; 32(7):1016-1024. PubMed ID: 28568506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined striatal binding and cerebral influx analysis of dynamic 11C-raclopride PET improves early differentiation between multiple-system atrophy and Parkinson disease.
    Van Laere K; Clerinx K; D'Hondt E; de Groot T; Vandenberghe W
    J Nucl Med; 2010 Apr; 51(4):588-95. PubMed ID: 20237023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral metabolic changes in early multiple system atrophy: a PET study.
    Taniwaki T; Nakagawa M; Yamada T; Yoshida T; Ohyagi Y; Sasaki M; Kuwabara Y; Tobimatsu S; Kira J
    J Neurol Sci; 2002 Aug; 200(1-2):79-84. PubMed ID: 12127681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.